Search Tag: bevacizumab

2019 30 Apr

Patients with advanced breast cancer benefit more through undergoing continuous chemotherapy which helps them both improve survival outcomes and maintain quality of life, as opposed to intermittent scheduling, according to new results of the Stop&Go study which will be presented at the ESMO Breast Cancer Congress 2-4 May, in Berlin, Germany....Read more

2017 12 Sep

The monoclonal antibody bevacizumab effectively inhibits angiogenesis in several types of cancers by blocking vascular endothelial growth factor. However, a new analysis reveals that treatment with bevacizumab increases the risk of arterial adverse events, particularly cardiac and cerebral ischaemia, venous adverse events, bleeding, and arterial hypertension....Read more

2017 09 May

The first study of its kind has been conducted by researchers in The Netherlands in which whole-body positron emission tomography/computed tomography (PET/CT) scans were used to determine whether bevacizumab (Avastin) treatment of diffuse intrinsic pontine glioma (DIPG) is likely to be effective in children suffering from brain cancer. The study is...Read more